AndhraNews.net
Home » Features » Health » Dengue

Dengue


Dengue in News

Aid to the Frontline: WWF-India and Apollo Hospitals Join Hands for Welfare of Forest Staff
Business Wire IndiaForest guards play an indispensable role in protecting the forest habitats and species that WWF-India strives to conserve. Their job involves patrolling vast swathes of often-inhospitable terrain with bare minimum protection and hardly any access to emergency medical facilities in case of any severe mishaps or illnesses suffered on-job

Over 100,000 Citizens of Delhi/NCR Come Together on LocalCircles for Blood Assistance of Dengue Victims
Business Wire India Blood platelets needs being met every day for Dengue patients Dengue  caregivers can access and seek blood or platelet assistance on Local Circles  Dengue victims can find a Blood Donor in local area within a couple of hours​   LocalCircles (https://www.localcircles

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

Vaccine Products in Development Have Tripled Over Last Decade, Tufts Center for the Study of Drug Development Study Says
Vaccine products in the R&D pipeline have more than tripled since 2005 and annual worldwide sales are on track to reach $40 billion by 2020, according to a recently completed study by the Tufts Center for the Study of Drug Development.

Terminix(R) Celebrates Mosquito Week With Release of Trailer for "Mosquitonado"
MEMPHIS, TN--(Marketwired - June 25, 2015) - Think mosquitoes are bad in your city this summer? You haven't seen anything yet.

Break Dengue Launches Global Social Movement at ASEAN Dengue Day 2015 to Make Dengue a Global Health Priority
Break Dengue, a global partnership of individuals and organizations engaged in the fight against dengue fever, is calling on citizens around the world to voice their concern about the growing social burden that represents dengue.

Three Recent iBioLaunch(TM) Platform Achievements to Be Presented at PBVAB 2015 Conference in Lausanne, Switzerland
iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, announced that three invited presentations focused on its products and technology will be given at the Sixth International Conference on Plant-Based Vaccines, Antibodies & Biologics today and tomorrow in Lausanne, Switzerland.

Ten Things to Know About the Chikungunya Virus
MosquitoNix®, the nation's leader in mosquito control and mosquito misting systems, is alerting the U.S. population about Chikungunya, a viral disease transmitted to humans by mosquitos. Historically, Chikungunya threatened areas in Africa and Asia. But in 2014, the virus arrived in the Americas for the first time

Andhra Pradesh News on July 15 , 2015
Andhra Pradesh News and Headlines on July 15, 2015

Andhra Pradesh News on May 20, 2015
Andhra Pradesh News and Headlines on May 20, 2015

Cocrystal Pharma, Inc. Announces Stock Symbol Change from BZNE to COCP
BOTHELL, WA--(Marketwired - April 16, 2014) - Cocrystal Pharma, Inc. (the "Company") (OTCQB: COCP) (OTCBB: BZNE), announced today that, effective April 15, 2014, the Company's stock began trading under the new symbol "COCP". The updated stock trading symbol marks the successful completion of the Company's recent merger with Biozone Pharmaceuticals, Inc., as announced on January 3, 2014.

Sierra Leone Pilot Study of 10 Minute Ebola Rapid Test Shows Promise
Medical diagnostic manufacturer JAJ International, Inc. (www.jajinternational.com) a subsidiary of LuSys Laboratories, Inc., receives promising results from a Sierra Leone Pilot Study for their Point of Care 10 Minute Ebola Rapid Test Diagnostic.

Cocrystal Pharma and RFS Pharma Merge to Create Advanced Antiviral Development Organization
BOTHELL, WA and ATLANTA, GA--(Marketwired - November 25, 2014) - Cocrystal Pharma, Inc. (OTCQB: COCP), a biotechnology company developing novel antiviral therapeutics for human diseases, today announced the closing of its merger with RFS Pharma, LLC, a privately owned biotech company founded by renowned drug developer, Dr. Raymond Schinazi

Insect Shield(R) Repellent Technology Tweaks Traditional Holiday BOGO With Super Hero Campaign to Help Protect Children From Malaria
Insect Shield®, known for their bug repellent apparel/gear technology, is launching a holiday Super Hero Blanket campaign to help protect at-risk children from malaria. Instead of a traditional buy one, get one free offer, Insect Shield is placing two protective blankets in the hands of a child in need for every purchase of one blanket online.

Cocrystal Pharma Reports Third Quarter Financial Results and Select Program Updates
BOTHELL, WA--(Marketwired - November 14, 2014) - Cocrystal Pharma, Inc. (the "Company") (OTCQB: COCP), a biotechnology company focused on developing new antiviral therapeutics for human diseases, today reported financial results for the third quarter ended September 30, 2014.

Novartis provides drug candidate compounds to TB Alliance
Novartis International AG /Novartis provides drug candidate compounds to TB Alliance. Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for the content of this announcement.

International Antiviral Therapeutics Report 2014-Technologies, Markets and Companies (Updated)
Research and Markets (http://www.researchandmarkets.com/research/rmhmmj/antiviral) has announced the addition of a new report "Antiviral Therapeutics - Technologies, Markets and Companies" to their offering.

Cocrystal Pharma Updates on Influenza Program
BOTHELL, WA--(Marketwired - April 30, 2014) - Cocrystal Pharma, Inc. (the "Company") (OTCBB: COCP) (OTCQB: COCP), a biotechnology company developing new antiviral therapeutics for human diseases, as a result of a recent BBC article titled "Tamiflu: Millions wasted on flu drug," would like to update stakeholders on its Influenza Program

Biozone Receives Strategic Investment From OPKO Health, Inc
BOTHELL, WA--(Marketwired - January 23, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has raised $2,750,000 from eight accredited investors including OPKO Health (NYSE MKT: OPK).

UPDATE: Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
ENGLEWOOD CLIFFS, NJ--(Marketwired - January 03, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Biozone Completes Acquisition of Cocrystal Discovery and Begins Transformation to High Growth Biotech Company
ENGLEWOOD CLIFFS, NJ--(Marketwired - January 03, 2014) - Biozone Pharmaceuticals, Inc. (OTCQB: BZNE) today announced that it has finalized its planned merger with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Terumo BCT and Banco de Sangre de Servicios Mutuos Unite in a Treatment Use Program Developed to Help Improve Blood Supply Safety Using an Investigational Device
Due to public health concerns over the transmission of chikungunya virus (CHIKV) and dengue fever, Terumo BCT will file a submission to the U.S. Food and Drug Administration (FDA) for expanded access use of the Mirasol® Pathogen Reduction Technology System for the treatment of platelets

Biocon Expands its Strategic Partnership with CytoSorbents for CytoSorb® to Treat SIRS and Cardiac Surgery Patients
Biocon Ltd (BSE code: 532523, NSE: BIOCON),  Asia's premier biopharmaceuticals company, and U.S

BioNet Appoints New COO and Accelerates the Development of New Recombinant Pertussis Vaccine
BioNet-Asia, a vaccine company focused on vaccine discovery and supply, announced that Georges Thiry has been appointed COO of the company, effective early 2015.

BioNet Provides Update on Recombinant Acellular Pertussis Vaccine at BioJapan 2014
BioNet-Asia's CEO, Dr Pham Hong Thai provided today an update on the company lead vaccine program in his presentation at BioJapan 2014. Dr Pham said that the current Phase I/II trial in Thailand showed that the vaccine is safe and immunogenic and full results will soon be published in a peer reviewed journal

Credihealth Organizes Blood Donation Camp as a Part of Credi Blood Donors Campaign
Credihealth, the leading online healthcare information services provider (http://www.credihealth.com/), organized a Blood Donation Camp on the occasion of World Blood Donation Day as a part of their Credi Blood Donors campaign

International SOS Sees Increase in Demand for Malaria Advice
Requests for advice from travellers, expatriates and overseas workers up 27% since 2010 11% of all International SOS medical cases attributed to infectious illnesses including malaria and dengue fever International SOS has seen a 27% rise in the number of calls for information and advice on malaria since 2010.   In 2013 the Group dealt with approximately 870 malaria cases worldwide

Health Issues on the Rise for Business Travellers: Increased Risk in a Changing World

Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company today announced that Michael Yorba of Clear Channel's Business Talk Radio Show, The Traders Network, interviewed CEO Dr. Eugene Seymour live on December 19, 2013.

NanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AM
NanoViricides, Inc. (NYSE MKT: NNVC) is a development stage company that is creating special purpose nanomaterials to destroy viruses in and on the body. The Company announced today that CEO Dr. Eugene Seymour will be interviewed live by Michal Yorba on Clear Channel Business Talk Radio's Traders Financial Network, Thursday, December 19th, 2013, at 2:00pm CST / 12:00pm PST / 3:00pm EST.

Biozone Pharmaceuticals Announces Executed Letter of Intent to Merge With Cocrystal Discovery Inc.
ENGLEWOOD CLIFFS, NJ--(Marketwired - November 27, 2013) - Biozone Pharmaceuticals, Inc. (OTCBB: BZNE) today announced that it has agreed to terms and signed a Letter of Intent to merge with Cocrystal Discovery, Inc., a privately-held, biotechnology company developing antiviral therapeutics for human diseases

Entrepreneur Torrey Tayenaka Helps Launch the Kite(TM) Patch
Orange County entrepreneur Torrey Tayenaka has helped launch yet another cutting-edge venture aimed at making a positive difference in the world. The release of the Kite™ Patch marks a significant advance in the global fight against mosquito-borne diseases such as malaria, West Nile Virus and Dengue Fever, and the company reached its $75,000 funding goal in just 4

New Strategy to Disarm the Dengue Virus Brings New Hope for a Universal Dengue Vaccine
A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may become the world's first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus

A*STAR and Veredus Laboratories Create Market's First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases
Singapore, April 25, 2013 - The Agency for Science, Technology and Research (A*STAR) and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.

Hawaii Biotech Gains Rights to West Nile Vaccine Technology From Merck
Hawaii Biotech, Inc

Eisai Co-establishes the Global Health Innovative Technology Fund
Eisai Co., Ltd. has co-established the Global Health Innovative Technology Fund (GHIT Fund) to advance the research and development of new medicines, vaccines, and diagnostics from Japan to fight infectious diseases in emerging countries and the developing world. The GHIT Fund is the first public-private partnership in Japan dedicated to the field of global health

A*STAR Scientist Alex Matter Awarded Prestigious Szent-Gyorgyi Prize For Progress In Cancer Research
Professor Alex Matter, Chief Executive Officer of A*STAR's Experimental Therapeutics Centre (ETC), has been awarded the 8th Annual Szent-Gyorgyi Prize for Progress in Cancer Research by the National Foundation for Cancer Research (NFCR) for his contributions to the development of the first drug specifically targeting a molecular lesion in cancer

MosquitoNix(R) Casts a Wider Net to Eliminate Mosquitoes Nationwide
MosquitoNix®, the nation's leader in mosquito control and mosquito misting systems, announced today that it is offering franchise opportunities for the first time in five years, primarily to existing outdoor service business owners. MosquitoNix® is expanding nationwide as part of a strategic plan to double its size in 2013, and open as many as 50 new franchises in 2013

Edison Awards Announces 2013 Finalists
The Edison Awards, celebrating its 26th year of honoring innovators and innovation, has announced its finalists for the internationally renowned 2013 Edison Awards. Since 1987, the Edison Awards have recognized game changing new products and services. Being recognized with an Edison Award has become one of the highest accolades a company can receive in the name of innovation and business.

Alliance of Translational Research Centres Established to Accelerate Global Drug Development
At the Canadian High Commission in London UK today, six of the world's top translational health research centres announced they have come together to form a new Global Alliance of Leading Drug Discovery and Development Centres

Eisai Begins Free Supply of Diethylcarbamazine in Line with its Global Commitment to Eliminate Lymphatic Filariasis
Eisai Pharmatechnology & Manufacturing Pvt. Ltd. (Headquarters: Visakhapatnam, President and Managing Director: Sanjit Singh Lamba) announced here today that it has begun the free supply of Diethylcarbamazine Citrate (DEC) 100 mg tablets produced at its Visakhapatnam Plant in India to the World Health Organization (WHO)

Tokyo Institute of Technology and Astellas Launch Collaborative Research for New Anti-Dengue Virus Drugs for Neglected Tropical Diseases
Tokyo Institute of Technology ("Tokyo Tech"; Tokyo, Japan; President: Yoshinao Mishima) and Astellas Pharma Inc. ("Astellas")(TOKYO:4503)(President and CEO: Yoshihiko Hatanaka) today announced that they have signed a joint research agreement for drug discovery research utilizing Tokyo Tech's TSUBAME2

Nagasaki University and Astellas Launch Collaborative Research for Screening New Anti-Dengue Virus Drugs for Neglected Tropical Diseases
The Nagasaki University ("Nagasaki University"; Nagasaki, Japan; President: Shigeru Katamine) and Astellas Pharma Inc

Takeda Highlights Data from Clinical Trial of Investigational Norovirus Vaccine Candidate
Takeda Pharmaceutical Company Limited (Takeda) announced today results of a Phase 1/2 study of its intramuscular bivalent (GI/GII) norovirus vaccine candidate in healthy adult volunteers who were challenged with the most commonly occurring norovirus (genotype GII.4) that causes gastroenteritis

Scientists and Clinicians Collaborate on 8 Projects to Better Understand and Treat Diseases Prevalent in Asia
Singapore announces 8 biomedical sciences research programmes to advance understanding and treatment of diseases especially prevalent amongst the Asian population. These programmes will see biomedical scientists and clinicians working collaboratively to bring about greater healthcare benefits to society and create economic growth for Singapore

Eisai Signs Global Agreement with Fundacao Oswaldo Cruz to Begin Development of New Medicines and Vaccines for Malaria and Neglected Tropical Diseases
Eisai Co., Ltd. announced today that it has signed a global agreement with Brazil's Fundacao Oswaldo Cruz ("Fiocruz") aimed at collaborations to develop new medicines and vaccines for malaria and neglected tropical diseases (NTDs)

Eisai Partners with the Sabin Vaccine Institute in an Effort to Develop Vaccines for Neglected Tropical Diseases
Eisai Co., Ltd. announced today that it has entered into a partnership agreement to supply the Sabin Vaccine Institute (Headquarters: Washington D.C., President: Dr

Successful Growth of BioDiem's Virus in VIVALIS EB66(R) Cell Line
Successful growth of BioDiem's Virus inVIVALIS EB66(®) Cell Line

Thomson Reuters Finds Increase in New Research for 'Neglected' Tropical Diseases
Despite recent gains, research still lags well behind that of 'first world' diseases

Andhra Pradesh News on September 10, 2012
Andhra Pradesh News and Headlines on September 10, 2012

Doctors ready to battle dengue as monsoon arrives in Kerala
Doctors are gearing up to combat the rising number of dengue cases here, as the arrival of monsoon results in a surge in such cases.

Ludhiana- based firms' dengue antidote caught in red tape despite clearing trials
Ayurvedic antidote for Dengue that cleared trials last year is awaiting an official go- ahead from the state authorities to facilitate its over the counter sale.

Kochi floating hospital a hit with locals
The floating hospital, built by the state government under the National Rural Health Mission (NRHM), is proving to be a big boon for locals.

Soil fungus kills mosquito that carries dengue fever
Researchers at the Queensland Institute of Medical Research have turned to a common fungus to stop the spread of dengue fever.

Mosquitoes incapable of transmitting malaria created
Researchers have produced a model of the Anopheles stephensi mosquito, which is a major source of malaria in India and the Middle East, that impairs the development of the malaria parasite.

'Switch' that boosts 'innate immunity' to ward off infectious diseases discovered
In a new study, scientists have for the first time identified the molecular 'switch' that directly triggers the body's first line of defence against pathogens, more accurately known as the body's "innate immunity".

Achilles heel of dengue virus identified
Scientists have identified the region on dengue virus that is neutralized in people who overcome infection with the deadly pathogen.

Dengue virus turns on mosquito genes 'making them hungrier'
Scientists have shown for the first time that infection with dengue virus turns on mosquito genes that makes them hungrier and better feeders, and therefore possibly more likely to spread the disease to humans.

Gene that transforms mild influenza to life-threatening disease identified
Researchers have identified for the first time a human gene that influences how we respond to influenza infection.

Drugs for diabetes and cancer may be used to treat dengue
Scientists have identified enzymes and biochemical compounds called lipids that are targeted and modified by the dengue virus during infection.

U.S. CDC develops new test for dengue fever
The U.S. Centers for Disease Control and Prevention (CDC) announced Wednesday that it has developed a new diagnostic test to detect the presence of dengue virus in people with symptoms of dengue fever or dengue hemorrhagic fever.

Protein biomarkers could allow early detection of 'deadly' dengue fever
Researchers have developed the first precise predictive model to distinguish between dengue fever (DF) and its more severe form, dengue hemorrhagic fever (DHF).

New therapies to treat Hepatitis C come closer to reality
Scientists have now identified a potential new method to block the lifecycle of the Hepatitis C virus, which could lead to new therapies for those affected by the disease.

Eng all-rounder Wright fears having contracted 'Dengue Fever' during IPL stint
England and Sussex all-rounder Luke Wright has revealed on his Twitter account that he has been told by the doctors he might have contracted Dengue Fever while playing for Pune Warriors in the lucrative Indian Premier League, and would be undergoing blood tests.

How dengue infection hits harder second time around
An international team of researchers has for the first time pulled apart the mechanism behind changing dengue virus genetics and dynamics of host immunity.

Spermless mosquitoes could prove effective in tackling dengue fever
A UK-based scientific team has modified male mosquitoes so that their offspring die before reproducing.

Genes behind susceptibility to severe dengue identified
Researchers in South East Asia have identified two genetic variants that offer clues as to why some people are more susceptible to severe dengue than others.

Our breath, body odours attract mosquitoes that spread deadly diseases
A new study has found that the carbon dioxide we exhale and the odours our skins emanate serve as crucial cues to female mosquitoes on the hunt for human hosts to bite and spread diseases such as malaria, dengue and yellow fever.

Why some people are better at fighting dengue fever
Scientists have for the first time discovered a part of our immune system that is involved in getting rid of dengue viruses, and also determines a person's ability to fight off the disease.

Pak ministers warn Sharif brothers against Zardari's character assassination
Pakistan Interior Minister Rehman Malik, Information Minister Dr Firdous Ashiq Awan and Senator Babar Awan have warned the Sharif brothers to refrain from character assassination of the President Asif Ali Zardari, and said that he would quit only after the completion of his five-year term.

PML-N to Zardari: Resign, return looted Pak wealth or face public wrath
Pakistan Muslim League-N (PML-N) leader and Punjab Chief Minister Shahbaz Sharif has called upon President Asif Ali Zardari to resign from his position and return looted national wealth.

Zardari Network more dangerous than Haqqanis for Pakistan: Nawaz Sharif
The 'Zardari Network' is more dangerous for Pakistan than the Haqqani network, as the Zardari-led government is bent upon destroying the institutions of the country, former Prime Minister Nawaz Sharif has said.

Andhra Pradesh News on October 25, 2011
Andhra Pradesh News and Headlines on October 25, 2011.

Dengue fever cases on rise in Ludhiana
Authorities in Ludhiana struggle to curb the alarmingly high cases of dengue fever.

Comment on this story

Share